Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$5.11bn229.83n/a
au flag iconMSBMesoblastAU$3.70bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$1.83bnn/an/a
au flag iconRACRace OncologyAU$816.60mn/an/a
au flag iconPYCPYC TherapeuticsAU$674.39mn/an/a
au flag iconIMMImmutepAU$445.42mn/an/a
au flag iconCGSCogstateAU$403.73m26.870.84%
au flag iconDXBDimerixAU$329.18mn/an/a
au flag iconTTXTetratherixAU$205.35mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$147.98mn/an/a
au flag iconLTPLtr PharmaAU$120.35mn/an/a
au flag iconALAArovella TherapeuticsAU$112.91mn/an/a
au flag iconATHAlterity TherapeuticsAU$109.53mn/an/a
au flag iconILAIsland PharmaceuticalsAU$99.16mn/an/a
au flag iconACWActinogen MedicalAU$98.49mn/an/a
au flag iconIMUImugeneAU$90.80mn/an/a
au flag iconBXNBioxyneAU$80.10m16.23n/a
au flag iconNYRNyradaAU$69.60mn/an/a
au flag iconADOAnteotechAU$62.22mn/an/a
au flag iconATXAmplia TherapeuticsAU$62.07mn/an/a